Our editorial workforce is celebrating the final 7 days of the year by recapping some of our most well-liked tales and material from the previous yr. Below, we are highlighting our most common articles related to diabetes technologies from 2022. Of be aware, this listing does not include regulatory news or guideline suggestions as equally of these subject areas were being lined in their very own calendar year in critique recaps.
Study Finds Dexcom G7 Setup is A lot easier, Needs Fewer Jobs for More mature Grownups than Earlier Generations
New facts from a smaller analyze evaluating relieve of uptake of the Dexcom G7 steady glucose checking method is underlining the impression of advancing technological know-how on accessibility and use of newer CGM systems as part of diabetic issues administration.
A 10-man or woman research assessing uptake of the Dexcom G7 CGM program among a inhabitants of older grown ups with the help of a accredited diabetic issues care and education and learning specialist, success suggest that G7 CGM procedure required fifty percent as many steps to established up and deploy as the G6 system, with the system’s program usability scale survey scores indicating superb usability.
Diabetes Dialogue: Optimizing CGM Uptake in Principal Care
In the first of 4 specific edition episodes from ADA 2022, Diabetic issues Dialogue hosts Drs. Diana Isaacs and Natalie Bellini take on the purpose of interviewers and discuss CGM uptake in primary treatment with Drs. Sean and Tamara Oser. Later on in the episode, the pair supply point of view on their encounters with Beta Bionics’ Insulin-Only Bionic Pancreas.
iLet Bionic Pancreas Improves Glycemic Management, Time in Target Assortment in Sort 1 Diabetes
Total information from the 13-week trial of the iLet insulin-only bionic pancreas specifics the improvements in glycemic management obtained with use of the bionic pancreas in older people and children with type 1 diabetes aged from as young as 6 a long time outdated and up to 79 years of age.
With funding from the Nationwide Institute of Diabetic issues and Digestive and Kidney Illnesses, results of the 13-7 days randomized demo propose use of BetaBionics’ iLet bionic pancreas was related with higher reductions in HbA1c than normal treatment, with all those using a bionic pancreas encounter a higher percentage of time in assortment as perfectly.
Elevated Scanning Frequency Improves Glucose Regulate, Hypoglycemia Panic in T1D Using CGM
Improved scanning can decrease anxiety of hypoglycemia amid persons with kind 1 diabetic issues utilizing intermittently scanned CGM systems, in accordance to the effects of a new analyze.
An analysis of scientific details and ambulatory glucose profile reviews from an outpatient clinic in Poland, final results of the review point out enhanced frequency of scanning with intermittently scanned CGM products was connected with make improvements to glycemic regulate and reduced panic of hypoglycemia among the men and women with type 1 diabetic issues.
Dexcom Announces Worldwide Launch of Dexcom G7 Glucose Monitoring System
The Dexcom G7 Continual Glucose Monitoring (CGM) Program rollout began on October 4 with the business asserting its availability for people with diabetic issues aged 2 a long time and more mature in the United Kingdom, Eire, Germany, Austria, and Hong Kong, with a rollout in New Zealand and South Africa expected inside the adhering to weeks.
